Literature DB >> 19137272

[Infections in hematology and oncology. Epidemiology--diagnosis--risk-adapted antimicrobial treatment--prevention].

G Maschmeyer1, M Sandherr.   

Abstract

Infections are the predominant complications in patients with hematological and oncological diseases undergoing chemotherapy or stem cell transplantation. The spectrum of causative pathogens depends on the suppression of granulopoiesis, T-cell immunity or humoral deficiency, so that recommendations for prevention, diagnostic approach and antimicrobial treatment should be specified for each cohort of patients. Following these rules, outcomes of prophylaxis and treatment today are favorable, although for some patient populations, the intensity of antimicrobial intervention has been reduced. Recommendations for prevention, including vaccination, should be known and followed for hospitalized as well as for out-patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19137272     DOI: 10.1007/s00108-008-2267-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  23 in total

1.  [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].

Authors:  W V Kern; J Beyer; A Böhme; D Buchheidt; O Cornely; H Einsele; J Kisro; W Krüger; G Maschmeyer; M Ruhnke; C A Schmidt; S Schwartz; H Szelenyi
Journal:  Dtsch Med Wochenschr       Date:  2000-12-22       Impact factor: 0.628

Review 2.  Updated guidelines on the management of cytomegalovirus reactivation in patients with chronic lymphocytic leukemia treated with alemtuzumab.

Authors:  Susan M O'Brien; Michael J Keating; Edward S Mocarski
Journal:  Clin Lymphoma Myeloma       Date:  2006-09

3.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease.

Authors:  Andrew J Ullmann; Jeffrey H Lipton; David H Vesole; Pranatharthi Chandrasekar; Amelia Langston; Stefano R Tarantolo; Hildegard Greinix; Wellington Morais de Azevedo; Vijay Reddy; Navdeep Boparai; Lisa Pedicone; Hernando Patino; Simon Durrant
Journal:  N Engl J Med       Date:  2007-01-25       Impact factor: 91.245

4.  Antiviral prophylaxis in patients with haematological malignancies and solid tumours: Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Oncology (DGHO).

Authors:  M Sandherr; H Einsele; H Hebart; C Kahl; W Kern; M Kiehl; G Massenkeil; O Penack; X Schiel; S Schuettrumpf; A J Ullmann; O A Cornely
Journal:  Ann Oncol       Date:  2006-01-12       Impact factor: 32.976

5.  Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial.

Authors:  B J Kullberg; J D Sobel; M Ruhnke; P G Pappas; C Viscoli; J H Rex; J D Cleary; E Rubinstein; L W P Church; J M Brown; H T Schlamm; I T Oborska; F Hilton; M R Hodges
Journal:  Lancet       Date:  2005 Oct 22-28       Impact factor: 79.321

6.  The Multinational Association for Supportive Care in Cancer risk index: A multinational scoring system for identifying low-risk febrile neutropenic cancer patients.

Authors:  J Klastersky; M Paesmans; E B Rubenstein; M Boyer; L Elting; R Feld; J Gallagher; J Herrstedt; B Rapoport; K Rolston; J Talcott
Journal:  J Clin Oncol       Date:  2000-08       Impact factor: 44.544

7.  Empirical antimicrobial monotherapy in patients after high-dose chemotherapy and autologous stem cell transplantation: a randomised, multicentre trial.

Authors:  Gernot Reich; Oliver A Cornely; Michael Sandherr; Thomas Kubin; Stefan Krause; Hermann Einsele; Eckhard Thiel; Tanja Bellaire; Bernd Dörken; Georg Maschmeyer
Journal:  Br J Haematol       Date:  2005-07       Impact factor: 6.998

8.  Anidulafungin versus fluconazole for invasive candidiasis.

Authors:  Annette C Reboli; Coleman Rotstein; Peter G Pappas; Stanley W Chapman; Daniel H Kett; Deepali Kumar; Robert Betts; Michele Wible; Beth P Goldstein; Jennifer Schranz; David S Krause; Thomas J Walsh
Journal:  N Engl J Med       Date:  2007-06-14       Impact factor: 91.245

9.  Diagnosis and antimicrobial therapy of pulmonary infiltrates in febrile neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO).

Authors:  Georg Maschmeyer; Thomas Beinert; Dieter Buchheidt; Hermann Einsele; Claus Peter Heussel; Michael Kiehl; Joachim Lorenz
Journal:  Ann Hematol       Date:  2003-09-09       Impact factor: 3.673

10.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group.

Authors:  Ben De Pauw; Thomas J Walsh; J Peter Donnelly; David A Stevens; John E Edwards; Thierry Calandra; Peter G Pappas; Johan Maertens; Olivier Lortholary; Carol A Kauffman; David W Denning; Thomas F Patterson; Georg Maschmeyer; Jacques Bille; William E Dismukes; Raoul Herbrecht; William W Hope; Christopher C Kibbler; Bart Jan Kullberg; Kieren A Marr; Patricia Muñoz; Frank C Odds; John R Perfect; Angela Restrepo; Markus Ruhnke; Brahm H Segal; Jack D Sobel; Tania C Sorrell; Claudio Viscoli; John R Wingard; Theoklis Zaoutis; John E Bennett
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.